Improved Efficacy and Fewer Side Effects Under Clozapine Treatment After Addition of Fluvoxamine
- 1 April 1995
- journal article
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 15 (2) , 141-143
- https://doi.org/10.1097/00004714-199504000-00012
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Effects of clozapine on positive and negative symptoms in outpatients with schizophreniaAmerican Journal of Psychiatry, 1994
- Disposition of clozapine in man: lack of association with debrisoquine and S‐mephenytoin hydroxylation polymorphisms.British Journal of Clinical Pharmacology, 1994
- Clozapine and N-desmethylclozapine are potent 5-HT1C receptor antagonistsEuropean Journal of Pharmacology: Molecular Pharmacology, 1993
- Fluvoxamine is a potent inhibitor of cytochrome P4501A2Biochemical Pharmacology, 1993
- Determination of clozapine and its major metabolites in human serum using automated solid-phase extraction and subsequent isocratic high-performance liquid chromatography with ultraviolet detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1992
- The effect of selective serotonin re‐uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes.British Journal of Clinical Pharmacology, 1992
- Fluvoxamine improves negative symptoms in treated chronic schizophrenia: An add-on double-blind, placebo-controlled studyBiological Psychiatry, 1992
- Dr. Perry and Associates ReplyAmerican Journal of Psychiatry, 1991
- Trial of fluoxetine added to neuroleptics for treatment-resistant schizophrenic patientsAmerican Journal of Psychiatry, 1990